$3,000 and a Toy: Novavax Dangles Incentives to Fill Clinical Trials on COVID Shots for Babies, Kids
August 30th, 2024Via: The Defender:
Novavax is offering parents up to $3,000 to enroll their children in the vaccine maker’s Phase 2/3 COVID-19 vaccine trial for infants and children ages 6 months to 11 years. The offer also includes a stuffed animal for each child.
The “Hummingbird” trial is testing two primary shots and a booster shot of Novavax’s adjuvanted recombinant spike protein nanoparticle vaccine in children. The study, which began in 2022, is enrolling 3,600 children.
The study, which began in the U.S., is expected to run through 2025 and will be conducted in the U.S. and other countries.
The children will receive three injections and visit the clinic eight times.
Selling your kid to Dr. Mengele. There must be other dimensions and other worlds, for sure, because this isn’t the Planet Earth I grew up on.
There are plenty of people who should never have had children.